glp-1 agonists names Letter: Association Between Incretin Mimetics and Medullary Thyroid Cancer GLP-1s and Hormone Therapy: A
Description
The complex pathophysiology and the metabolic risk factors shared between type 2 diabetes, obesity, CKD and cardiovascular disease have led to the concept of a cardiovascularkidneymetabolic (CKM) syndrome
Accessed August 24, 2016
Lehrke M, Marx N, Patel S, et al
Despite overlapping benefits, growing evidence suggests that these agents have distinct and complementary roles in clinical practice
